先天性长QT综合征致病基因的国际多中心循证再评估
该研究利用循证框架,由3个独立基因评审团队对17个曾报道导致长QT综合征的基因进行证据评分,最终仅KCNQ1、KCNH2、SCN5A被分类为典型长QT综合征的明确致病基因,超过半数基因证据有限或存在争议。
要点
- 仅KCNQ1、KCNH2、SCN5A为典型长QT综合征的明确致病基因。
- 9个基因证据有限或存在争议,不应用于临床决策。
- CALM1-3和TRDN为非典型长QT综合征(含新生儿房室传导阻滞)的强/明确证据基因。
核心结论
- 超过半数曾报道导致长QT综合征的基因证据有限或存在争议,不应据此进行临床决策。
研究设计与样本
- 国际多中心研究,3个基因评审团队 blinded 独立对17个报道导致长QT综合征的基因进行证据评分,临床域通道病工作组最终分类。
主要发现
- 17个基因中,9个(AKAP9、ANK2、CAV3、KCNE1、KCNE2、KCNJ2、KCNJ5、SCN4B、SNTA1)被分类为证据有限或存在争议。
- 仅3个基因(KCNQ1、KCNH2、SCN5A)被评审为典型长QT综合征的明确致病基因。
- 4个基因(CALM1、CALM2、CALM3、TRDN)在非典型长QT综合征(包括新生儿房室传导阻滞)中具有强或明确致病证据。
- CACNA1C具有中等水平证据导致长QT综合征。
临床怎么用
- 对证据有限或存在争议的基因变异,除非有新的充分遗传学证据,否则不应用于临床决策。
- 临床基因检测应优先关注KCNQ1、KCNH2、SCN5A等明确致病基因。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Long QT syndrome (LQTS) is the first described and most common inherited arrhythmia. Over the last 25 years, multiple genes have been reported to cause this condition and are routinely tested in patients. Because of dramatic changes in our understanding of human genetic variation, reappraisal of reported genetic causes for LQTS is required. METHODS: Utilizing an evidence-based framework, 3 gene curation teams blinded to each other's work scored the level of evidence for 17 genes reported to cause LQTS. A Clinical Domain Channelopathy Working Group provided a final classification of these genes for causation of LQTS after assessment of the evidence scored by the independent curation teams. RESULTS: Of 17 genes reported as being causative for LQTS, 9 (AKAP9, ANK2, CAV3, KCNE1, KCNE2, KCNJ2, KCNJ5, SCN4B, SNTA1) were classified as having limited or disputed evidence as LQTS-causative genes. Only 3 genes (KCNQ1, KCNH2, SCN5A) were curated as definitive genes for typical LQTS. Another 4 genes (CALM1, CALM2, CALM3, TRDN) were found to have strong or definitive evidence for causality in LQTS with atypical features, including neonatal atrioventricular block. The remaining gene (CACNA1C) had moderate level evidence for causing LQTS. CONCLUSIONS: More than half of the genes reported as causing LQTS have limited or disputed evidence to support their disease causation. Genetic variants in these genes should not be used for clinical decision-making, unless accompanied by new and sufficient genetic evidence. The findings of insufficient evidence to support gene-disease associations may extend to other disciplines of medicine and warrants a contemporary evidence-based evaluation for previously reported disease-causing genes to ensure their appropriate use in precision medicine.
引用
- Adler A, Novelli V, Amin AS, et al. An International, Multicentered, Evidence-Based Reappraisal of Genes Reported to Cause Congenital Long QT Syndrome. Circulation. 2020. PMID: 31983240. doi:10.1161/CIRCULATIONAHA.119.043132
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。